Blue Cross NC policies

Search Blue Cross NC's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

Checking prior authorization for 84999? Open Blue Cross NC’s official lists and confirm the member’s product there.

37 policies name 84999, those listing the fewest codes first. A policy that names a code may also list it as excluded.

Blue Cross NC policies
PolicyDetailsCodesSource
Pancreatic Cancer Risk Testing Using Molecular Classifier in Pancreatic Cyst Fluid AHS-M2114AHS-M2114 · Commercial2Original policy ↗
Quantose Impaired Glucose Tolerance (IGT) Test AHS - G2135G2135 · Commercial2Original policy ↗
Fibromyalgia Testing AHS - M2177M2177 · Commercial3Original policy ↗
Vitamin B12 and Methylmalonic Acid Testing AHS – G2014G2014 · Commercial3Original policy ↗
Serum Testing for Evidence of Mild Traumatic Brain Injury AHS - G2151G2151 · Commercial4Original policy ↗
Vitamin B12 and Methylmalonic Acid Testing AHS - G2014G2014 · Commercial4Original policy ↗
Vitamin B12 and Methylmalonic Acid Testing AHS – G2014 NotificationG2014 · Commercial4Original policy ↗
Multigene Expression Assay for Predicting Colon Cancer Recurrence AHS-M2111AHS-M2111 · Commercial6Original policy ↗
Diagnostic Testing of Iron Homeostasis and Metabolism AHS - G2011 NotificationG2011 · Commercial7Original policy ↗
Diagnostic Testing of Iron Homeostasis and Metabolism AHS – G2011 NotificationG2011 · Commercial7Original policy ↗
Laboratory Procedures Reimbursement Policy AHS - R2162R2162 · Commercial7Original policy ↗
Diagnostic Testing of Iron Homeostasis and Metabolism AHS - G2011G2011 · Commercial8Original policy ↗
Molecular Panel Testing of Cancers to Identify Targeted Therapy AHS - M2109M2109 · Commercial8Original policy ↗
Pancreatic Cancer Risk Testing Using Pancreatic Cyst Fluid AHS - M2114M2114 · Commercial10Original policy ↗
Immunopharmacologic Monitoring of Therapeutic Serum Antibodies AHS - G2105G2105 · Commercial11Original policy ↗
Serum Testing for Hepatic Fibrosis in the Evaluation and Monitoring of Chronic Liver Disease AHS - G2110G2110 · Commercial12Original policy ↗
Serum Testing for Hepatic Fibrosis in the Evaluation and Monitoring of Chronic Liver Disease AHS - G2110G2110 · Commercial12Original policy ↗
Biomarkers for Myocardial Infarction and Chronic Heart Failure AHS – G2150G2150 · Commercial15Original policy ↗
Biomarkers for Myocardial Infarction and Chronic Heart Failure AHS - G2150G2150 · Commercial17Original policy ↗
Transplant Rejection Testing AHS - M2091M2091 · Commercial21Original policy ↗
Molecular Diagnostics for Breast Cancer Prognosis AHS - M2020M2020 · Commercial22Original policy ↗
Transplant Rejection Testing AHS - M2091 NotificationM2091 · Commercial24Original policy ↗
Micronutrient Testing AHS – G2099G2099 · Commercial26Original policy ↗
Intracellular Micronutrient Analysis AHS – G2099G2099 · Commercial27Original policy ↗
Diagnosis of Idiopathic Environmental Intolerance AHS – G2056G2056 · Commercial39Original policy ↗
Professional Pathology Billing Requirements AHS – R2169R2169 · Commercial41Original policy ↗
Diagnosis of Idiopathic Environmental Intolerance AHS - G2056G2056 · Commercial55Original policy ↗
Diagnosis of Idiopathic Environmental Intolerance AHS - G2056 NotificationG2056 · Commercial55Original policy ↗
Cardiovascular Disease Risk Assessment AHS – G2050G2050 · Commercial56Original policy ↗
Cardiovascular Disease Risk Assessment AHS – G2050G2050 · Commercial60Original policy ↗
Cardiovascular Disease Risk Assessment AHS – G2050 NotificationAHS-G2050 · Commercial60Original policy ↗
Serum Tumor Markers for Malignancies AHS - G2124G2124 · Commercial78Original policy ↗
Laboratory Procedures Medical Policy AHS - R2162 NotificationAHS - R2162 · Commercial84Original policy ↗
Laboratory Procedures Medical Policy AHS - R2162AHS - R2162 · Commercial93Original policy ↗
Laboratory Procedures Medical Policy AHS - R2162 NotificationAHS - R2162 · Commercial95Original policy ↗
Prenatal Screening AHS – G2035G2035 · Commercial106Original policy ↗
The Blue Book Provider e-ManualCommercial, Medicaid503Original policy ↗

Back to Blue Cross NC · Blue Cross NC prior authorization CPT list

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.